Epstein Barr Virus Antibody Panel (Quantitative)
Also known as: EBV Comprehensive, Infectious Mononucleosis Panel
Use
Primary infection by EBV causes infectious mononucleosis, usually a self‑limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA‑IgM is typically detectable at clinical presentation, then declines to undetectable levels within a month in young children and within 3 months in other individuals. VCA‑IgG is typically detectable at clinical presentation and persists for life. EBNA IgG typically appears during convalescence (3‑4 months after clinical presentation) and remains detectable for life.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
EBV Nuclear Antigen (EBNA) IgG
AnalyteEBV Viral Capsid Antigen (VCA) IgG
AnalyteEBV Viral Capsid Antigen (VCA) IgM
Analyte
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL blood; test volume 1 mL serum; minimum volume 0.8 mL serum
Minimum Volume
0.8 mL serum
Container
Red Top (No Additive)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 4 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant